文献速递淋巴瘤

单细胞分析可揭示滤泡性淋巴瘤不同肿瘤部位的独立演化

Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma.
PubMed 文献 · Blood · 2021-01-01

该研究对10例滤泡性淋巴瘤患者的2个同步获取的淋巴结肿瘤样本进行单细胞RNA、BCR和TCR测序及流式细胞术分析,发现部分患者两部位共享BCR亚克隆,但多数患者肿瘤独立演化、细胞迁移有限;BCR演化差异伴随基因表达和细胞表面蛋白谱差异,且肿瘤异质性与Tfh细胞丰度相关。

要点

  • 滤泡性淋巴瘤不同肿瘤部位可存在独立BCR演化,单次活检可能无法代表整体疾病。
  • BCR演化差异伴随肿瘤基因表达和细胞表面蛋白谱差异。
  • 肿瘤与Tfh细胞间CD40-CD40LG配体-受体对富集,肿瘤CD40表达与Tfh增殖相关。

核心结论

  • 滤泡性淋巴瘤不同肿瘤部位可独立演化,BCR亚克隆共享程度因患者而异。

研究设计与样本

  • 对10例滤泡性淋巴瘤患者的2个同步获取的淋巴结肿瘤样本进行单细胞RNA、BCR和TCR测序及流式细胞术分析。

主要发现

  • 部分患者两肿瘤部位共享BCR亚克隆,但多数患者疾病独立演化且肿瘤细胞迁移有限。
  • BCR演化差异的患者也表现出肿瘤基因表达和细胞表面蛋白谱差异。
  • 肿瘤微环境整体组成在部位间无显著差异,但肿瘤异质性与Tfh细胞丰度相关。
  • 肿瘤与Tfh细胞间富集CD40-CD40LG等配体-受体对,肿瘤CD40表达与Tfh增殖显著相关。

临床怎么用

  • 提示单次活检可能难以全面反映滤泡性淋巴瘤患者的疾病状态。
  • 可能解释系统性治疗应答不一致,支持需关注肿瘤部位异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tumor heterogeneity complicates biomarker development and fosters drug resistance in solid malignancies. In lymphoma, our knowledge of site-to-site heterogeneity and its clinical implications is still limited. Here, we profiled 2 nodal, synchronously acquired tumor samples from 10 patients with follicular lymphoma (FL) using single-cell RNA, B-cell receptor (BCR) and T-cell receptor sequencing, and flow cytometry. By following the rapidly mutating tumor immunoglobulin genes, we discovered that BCR subclones were shared between the 2 tumor sites in some patients, but in many patients, the disease had evolved separately with limited tumor cell migration between the sites. Patients exhibiting divergent BCR evolution also exhibited divergent tumor gene-expression and cell-surface protein profiles. While the overall composition of the tumor microenvironment did not differ significantly between sites, we did detect a specific correlation between site-to-site tumor heterogeneity and T follicular helper (Tfh) cell abundance. We further observed enrichment of particular ligand-receptor pairs between tumor and Tfh cells, including CD40 and CD40LG, and a significant correlation between tumor CD40 expression and Tfh proliferation. Our study may explain discordant responses to systemic therapies, underscores the difficulty of capturing a patient's disease with a single biopsy, and furthers our understanding of tumor-immune networks in FL.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Haebe S, Shree T, Sathe A, et al. Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma. Blood. 2021. PMID: 33728464. doi:10.1182/blood.2020009855

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。